Large-scale (Phase III) evaluation of broflanilide 50WP (VECTRON™ T500) for indoor residual spraying for malaria vector control in Northeast Tanzania: study protocol for a two-arm, non-inferiority, cluster-randomised community trial

Patrick K Tungu, Mark W Rowland, Louisa A Messenger, Graham J Small, John Bradley, Janneke Snetselaar, Matthew J Kirby, Njelembo J Mbewe, Patrick K Tungu, Mark W Rowland, Louisa A Messenger, Graham J Small, John Bradley, Janneke Snetselaar, Matthew J Kirby, Njelembo J Mbewe

Abstract

Background: Indoor residual spraying (IRS) is a major method of malaria vector control across sub-Saharan Africa. Effective control is being undermined by the rapid spread of insecticide resistance. There is major investment in development of new insecticides for IRS that possess novel modes of action, long residual activity, low mammalian toxicity and minimal cross-resistance. VECTRON™ T500, a new IRS product containing the active ingredient broflanilide as a 50% wettable powder (WP), has been shown to be efficacious against pyrethroid susceptible and resistant vector species on mud and concrete substrates in experimental hut (Phase II) trials.

Methods: A two-arm non-inferiority cluster randomized controlled trial (Phase III) will be undertaken in Muheza District, Tanga Region, Tanzania. VECTRON™ T500 will be compared to the IRS product Fludora® Fusion (clothianidin 50% WP + deltamethrin 6.25% WP). The predominant malaria vectors in the study area are pyrethroid-resistant Anopheles gambiae s.s., An. arabiensis and An. funestus s.s. Sixteen village clusters will be pair-matched on baseline vector densities and allocated to reference and intervention arms. Consenting households in the intervention arm will be sprayed with VECTRON™ T500 and those in the reference arm will be sprayed with Fludora® Fusion. Each month, CDC light traps will collect mosquitoes to estimate changes in vector density, indoor biting, sporozoite and entomological inoculation rates (EIR). Susceptibility to IRS active ingredients will be assessed using World Health Organisation (WHO) bottle bioassays. Target site and metabolic resistance mechanisms will be characterised among Anopheles field populations from both trial arms. Residual efficacy of both IRS products will be monitored for 12 months post intervention. Questionnaire and focus group discussions will explore factors that influence adherence, adverse effects and benefits of IRS.

Discussion: This protocol describes a large-scale non-inferiority evaluation of a novel IRS product to reduce the density and EIR of pyrethroid-resistant Anopheles vectors. If VECTRON™ T500 proves non-inferior to Fludora® Fusion, it will be considered as an additional vector control product for malaria prevention and insecticide resistance management.

Trial registration: ClinicalTrials.gov, NCT05150808, registered on 26 November 2021. Retrospectively registered.

Keywords: Broflanilide; Clothianidin; Entomological inoculation rate; Indoor residual spraying; Insecticide resistance; Vector density.

Conflict of interest statement

The authors declare that they have no competing interests.

© 2022. The Author(s).

Figures

Fig. 1
Fig. 1
Study area A location of Muheza District in Northeast Tanzania; B proposed clusters in Muheza District. The maps of Tanzania and Muheza district were produced using QGIS 3.22 software [44] and overlaid on Google Earth satellite images by the study investigator (NJM). Using QGIS 3.22 software [44], a one kilometre transect from the mid-point to the perimeter of each village was digitized to produce the shape files for the clusters in the Muheza map

References

    1. World Health Organization. Global plan for insecticide resistance management in malaria vectors. 2012. .
    1. Bhatt S, Weiss DJ, Cameron E, Bisanzio D, Mappin B, Dalrymple U, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature. 2015;526:207–211. doi: 10.1038/nature15535.
    1. World Health Organization. World Malaria Report 2020: 20 years of global progress and challenges. Geneva, Switzerland: World Health Organisation; 2020. .
    1. Oxborough RM. Trends in US President’s Malaria Initiative-funded indoor residual spray coverage and insecticide choice in sub-Saharan Africa (2008–2015): Urgent need for affordable, long-lasting insecticides. Malar J. 2016;15:1–9. doi: 10.1186/s12936-016-1201-1.
    1. MacDonald G. The epidemiology and control of malaria. London, UK: Oxford University Press; 1957.
    1. Pluess B, Tanser FC, Lengeler C, Sharp BL. Indoor residual spraying for preventing malaria. Cochrane Database Syst Rev. 2010 doi: 10.1002/14651858.CD006657.pub2.
    1. Sharp BL, Kleinschmidt I, Streat E, Maharaj R, Barnes KI, Durrheim DN, et al. Seven years of regional malaria control collaboration—Mozambique, South Africa, and Swaziland. Am J Trop Med Hyg. 2007;76:42–47. doi: 10.4269/ajtmh.2007.76.42.
    1. Kleinschmidt I, Rowland M. Insecticides and malaria. In: Koenraadt CJM, Spitzen J, Takken W, editors. Innovative strategies for vector control-Ecology and control of vector-borne diseases. Wageningen: Wageningen Academic Publishers; 2021. pp. 17–32.
    1. Hargreaves K, Koekemoer LL, Brooke BD, Hunt RH, Mthembu J, Coetzee M. Anopheles funestus resistant to pyrethroid insecticides in South Africa. Med Vet Entomol. 2000;14:181–189. doi: 10.1046/j.1365-2915.2000.00234.x.
    1. Hargreaves K, Hunt RH, Brooke BD, Mthembu J, Weeto MM, Awolola TS, et al. Anopheles arabiensis and An. quadriannulatus resistance to DDT in South Africa. Med Vet Entomol. 2003;17:417–422. doi: 10.1111/j.1365-2915.2003.00460.x.
    1. Curtis GF, Miller JE, Hodjati MH, Kolaczinski JH, Kasumba I. Can anything be done to maintain the effectiveness of pyrethroid-impregnated bednets against malaria vectors? Philos Trans R Soc B Biol Sci. 1998;353:1769–1775. doi: 10.1098/rstb.1998.0329.
    1. Clarke SE, Bøgh C, Brown RC, Pinder M, Walraven GEL, Lindsay SW. Do untreated bednets protect against malaria? Trans R Soc Trop Med Hyg. 2001;95:457–462. doi: 10.1016/S0035-9203(01)90001-X.
    1. Kolaczinski JH, Fanello C, Hervé J-P, Conway DJ, Carnevale P, Curtis CF. Experimental and molecular genetic analysis of the impact of pyrethroid and non-pyrethroid insecticide impregnated bednets for mosquito control in an area of pyrethroid resistance. Bull Entomol Res. 2000;90:125–132. doi: 10.1017/S0007485300000237.
    1. Bradley J, Matias A, Schwabe C, Vargas D, Monti F, Nseng G, et al. Increased risks of malaria due to limited residual life of insecticide and outdoor biting versus protection by combined use of nets and indoor residual spraying on Bioko Island, Equatorial Guinea. Malar J. 2012;11:1–9. doi: 10.1186/1475-2875-11-242.
    1. Oxborough RM, Kitau J, Jones R, Feston E, Matowo J, Mosha FW, et al. Long-lasting control of Anopheles arabiensis by a single spray application of micro-encapsulated pirimiphos-methyl (Actellic® 300 CS) Malar J. 2014 doi: 10.1186/1475-2875-13-37.
    1. Rowland M, Boko P, Odjo A, Asidi A, Akogbeto M, N’Guessan R. A new long-lasting indoor residual formulation of the organophosphate insecticide Pirimiphos methyl for prolonged control of pyrethroid-resistant mosquitoes: an experimental hut trial in Benin. PLoS ONE. 2013;8:1–10. doi: 10.1371/journal.pone.0069516.
    1. Weill M, Malcolm C, Chandre F, Mogensen K, Berthomieu A, Marquine M, et al. The unique mutation in ace-1 giving high insecticide resistance is easily detectable in mosquito vectors. Insect Mol Biol. 2004;13:1–7. doi: 10.1111/j.1365-2583.2004.00452.x.
    1. Oxborough RM, Seyoum A, Yihdego Y, Dabire R, Gnanguenon V, Wat’Senga F, et al. Susceptibility testing of Anopheles malaria vectors with the neonicotinoid insecticide clothianidin; results from 16 African countries, in preparation for indoor residual spraying with new insecticide formulations. Malar J. 2019;18:1–11. doi: 10.1186/s12936-019-2888-6.
    1. WHO. List of WHO prequalified Vector Control Products. 2020. . Accessed 1 Nov 2021.
    1. Snetselaar J, Rowland MW, Manunda BJ, Kisengwa EM, Small GJ, Malone DJ, et al. Efficacy of indoor residual spraying with broflanilide (TENEBENAL), a novel meta-diamide insecticide, against pyrethroid- resistant anopheline vectors in northern Tanzania: an experimental hut trial. PLoS ONE. 2021;16:e0248026. doi: 10.1371/journal.pone.0248026.
    1. Nakao T, Banba S. Broflanilide: a meta-diamide insecticide with a novel mode of action. Bioorg Med Chem. 2016;24:372–377. doi: 10.1016/j.bmc.2015.08.008.
    1. IRAC. IRAC Mode of Action Classification Scheme. IRAC; 2021. .
    1. World Health Organization. Data requirements and protocol for determining non-inferiority of insecticide-treated net and indoor residual spraying products within an established WHO policy class (WHO/CDS/GMP/2018.22.Rev.1.). 2019. .
    1. National Bureau of Statistics. 2012 Population and housing census. Dar es Salaam, Tanzania.: National Bureau of Statistics; 2012.
    1. Mtove G, Mugasa JP, Messenger LA, Malima RC, Mangesho P, Magogo F, et al. The effectiveness of non-pyrethroid insecticide-treated durable wall lining to control malaria in rural Tanzania: study protocol for a two-armed cluster randomized trial. BMC Public Health. 2016;16:633. doi: 10.1186/s12889-016-3287-3.
    1. Kabula B, Tungu P, Malima R, Rowland M, Minja J, Wililo R, et al. Distribution and spread of pyrethroid and DDT resistance among the Anopheles gambiae complex in Tanzania. Med Vet Entomol. 2014;28:244–252. doi: 10.1111/mve.12036.
    1. Protopopoff N, Mosha JF, Lukole E, Charlwood JD, Wright A, Mwalimu CD, et al. Effectiveness of a long-lasting piperonyl butoxide-treated insecticidal net and indoor residual spray interventions, separately and together, against malaria transmitted by pyrethroid-resistant mosquitoes: a cluster, randomised controlled, two-by-two fact. Lancet. 2018;391:1577–1588. doi: 10.1016/S0140-6736(18)30427-6.
    1. Hayes RJ, Moulton LH. Cluster randomised trials. 2. Boca Raton: Chapman and Hall/CRC; 2017.
    1. WHO. Test procedures for insecticide resistance monitoring in malaria vector mosquitoes. 2nd edn. Geneva, Switzerland: WHO; 2018. .
    1. CDC. Guideline for evaluating insecticide resistance in vectors using the CDC bottle bioassay. Atlanta: CDC; 2010. .
    1. Gillies MT, De Meillon B. The Anophelinae of Africa South of the Sahara (Ethiopian Zoogeographical Region). 2nd edn. Johannesburg: South African Institute for Medical Research; 1968.
    1. Bass C, Nikou D, Donnelly MJ, Williamson MS, Ranson H, Ball A, et al. Detection of knockdown resistance (kdr) mutations in Anopheles gambiae: a comparison of two new high-throughput assays with existing methods. Malar J. 2007;6:111. doi: 10.1186/1475-2875-6-111.
    1. Bass C, Williamson MS, Field LM. Development of a multiplex real-time PCR assay for identification of members of the Anopheles gambiae species complex. Acta Trop. 2008;107:50–53. doi: 10.1016/j.actatropica.2008.04.009.
    1. Burkot TR, Williams JL, Schneider I. Identification of Plasmodium falciparum-infected mosquitoes by a double antibody enzyme-linked immunosorbent assay. Am J Trop Med Hyg. 1984;33:783–788. doi: 10.4269/ajtmh.1984.33.783.
    1. Matowo J, Weetman D, Pignatell P, Wright A, Charlwood JD, Kaaya R, et al. Insecticide resistance characteristic of Anopheles vector species successfully controlled by deployment of pyrethroid and PBO long lasting insecticidal treated nets in Tanzania. bioRxiv. 2021. .
    1. Vezenegho SB, Bass C, Puinean M, Williamson MS, Field LM, Coetzee M, et al. Development of multiplex real-time PCR assays for identification of members of the Anopheles funestus species group. Malar J. 2009;8:1–9. doi: 10.1186/1475-2875-8-282.
    1. Riveron JM, Yunta C, Ibrahim SS, Djouaka R, Irving H, Menze BD, et al. A single mutation in the GSTe2 gene allows tracking of metabolically based insecticide resistance in a major malaria vector. Genome Biol. 2014;15:1–20. doi: 10.1186/gb-2014-15-2-r27.
    1. Weedall GD, Mugenzi LMJ, Menze BD, Tchouakui M, Ibrahim SS, Amvongo-Adjia N, et al. A cytochrome P450 allele confers pyrethroid resistance on a major African malaria vector, reducing insecticide-treated bednet efficacy. Sci Transl Med. 2019 doi: 10.1126/scitranslmed.aat7386.
    1. Mugenzi LMJ, Menze BD, Tchouakui M, Wondji MJ, Irving H, Tchoupo M, et al. Cis-regulatory CYP6P9b P450 variants associated with loss of insecticide-treated bed net efficacy against Anopheles funestus. Nat Commun. 2019;10:4652. doi: 10.1038/s41467-019-12686-5.
    1. WHO. Guidelines for testing mosquito adulticides for indoor residual spraying and treatment of mosquito nets. Geneva, Switzerland: WHO; 2006. .
    1. WHO. Generic risk assessment model risk model for indoor residual spraying of insecticides. 2nd edn. Geneva: WHO; 2018. .
    1. Rose P, Tenebenal TM. IRS human safety assessment for submission to the LSHTM and national ethics committees. Report NO: 0387820-TOX2. (Unpublished). 2020.
    1. Rowland M, Protopopoff N. Dawn of the PBO-pyrethroid long lasting net—light at last. Outlooks Pest Manag. 2018;29:242–244. doi: 10.1564/v29_dec_01.
    1. QGIS Development Team. QGIS Geographic Information System. 2021. .

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit